首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >A High Percentage of Serum Samples That Test Reactive by Enzyme Immunoassay for Anti-Brucella Antibodies Are Not Confirmed by the Standard Tube Agglutination Test
【2h】

A High Percentage of Serum Samples That Test Reactive by Enzyme Immunoassay for Anti-Brucella Antibodies Are Not Confirmed by the Standard Tube Agglutination Test

机译:标准试管凝集试验无法确定通过酶联免疫吸附法检测抗小球藻抗体的高浓度血清样品

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe a retrospective analysis of Brucella enzyme immunoassay (EIA) IgM and IgG results compared to those of the standard tube agglutination test (SAT). Among 1,091 samples tested, 104 (9.5%) and 24 (2.2%) sera were positive by IgM and IgG EIA, respectively. Supplemental testing by SAT showed that 82.7% (86/104) of IgM EIA-reactive samples and 54.2% (13/24) of IgG EIA-reactive samples were negative by SAT. Testing all EIA screen-reactive samples by SAT is required when evaluating patients for potential brucellosis. Due to the limitations of serology, culture remains the gold standard for detecting Brucella infection.
机译:我们描述了布鲁氏菌酶免疫测定(EIA)IgM和IgG结果与标准试管凝集试验(SAT)相比的回顾性分析。在测试的1,091个样本中,IgM和IgG EIA分别为104(9.5%)和24(2.2%)血清阳性。 SAT的补充测试显示,SAT阴性的IgM EIA反应性样品为82.7%(86/104),而IgG EIA活性样品为54.2%(13/24)为阴性。在评估患者潜在布鲁氏菌病时,需要通过SAT测试所有EIA屏幕反应性样本。由于血清学的局限性,培养仍然是检测布鲁氏菌感染的金标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号